158 related articles for article (PubMed ID: 9442283)
1. Development and strategic use of alternative tests in assessing the hazard of chemicals.
Purchase IF
Arch Toxicol Suppl; 1998; 20():71-80. PubMed ID: 9442283
[No Abstract] [Full Text] [Related]
2. Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals.
Crofton KM; Mundy WR; Lein PJ; Bal-Price A; Coecke S; Seiler AE; Knaut H; Buzanska L; Goldberg A
ALTEX; 2011; 28(1):9-15. PubMed ID: 21311847
[TBL] [Abstract][Full Text] [Related]
3. Integrated testing strategies for use in the EU REACH system.
Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
Altern Lab Anim; 2006 Aug; 34(4):407-27. PubMed ID: 16945008
[TBL] [Abstract][Full Text] [Related]
4. Re: "Comparison of in vivo (Draize method) and in vitro (Corrositex assay) dermal corrosion values for selected industrial chemicals".
Ulmer WR
Int J Toxicol; 2003; 22(6):475-6; author response 476-8. PubMed ID: 14680995
[No Abstract] [Full Text] [Related]
5. A review of the status of alternative approaches to animal testing and the development of integrated testing strategies for assessing the toxicity of chemicals under REACH--a summary of a DEFRA-funded project conducted by Liverpool John Moores University and FRAME.
Grindon C; Combes R; Cronin MT; Roberts DW; Garrod J
Altern Lab Anim; 2006 Mar; 34 Suppl 1():149-58. PubMed ID: 16555968
[TBL] [Abstract][Full Text] [Related]
6. Introduction to the EU REACH legislation.
Grindon C; Combes R
Altern Lab Anim; 2006 Mar; 34 Suppl 1():5-10. PubMed ID: 16555955
[TBL] [Abstract][Full Text] [Related]
7. Development of integrated testing strategies for REACH: motivation, background and introduction. Preface.
Cronin MT; Garrod JF; Balls M
Altern Lab Anim; 2008 Oct; 36 Suppl 1():i-iii. PubMed ID: 19130698
[No Abstract] [Full Text] [Related]
8. Food for thought ... why no new in vitro tests will be done for REACH by registrants.
Rovida C
ALTEX; 2010; 27(3):175-83. PubMed ID: 21113560
[No Abstract] [Full Text] [Related]
9. Formation of mechanistic categories and local models to facilitate the prediction of toxicity.
Cronin MT; Enoch SJ; Hewitt M; Madden JC
ALTEX; 2011; 28(1):45-9. PubMed ID: 21311849
[TBL] [Abstract][Full Text] [Related]
10. The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment.
Hareng L; Pellizzer C; Bremer S; Schwarz M; Hartung T
Reprod Toxicol; 2005; 20(3):441-52. PubMed ID: 15899576
[TBL] [Abstract][Full Text] [Related]
11. Novel strategies for toxicological risk assessments.
Roy A; Akbarsha MA
ALTEX; 2014; 31(1):91-3. PubMed ID: 24448760
[No Abstract] [Full Text] [Related]
12. Evidence-Based Toxicology Collaboration (EBTC). Editorial.
von Aulock S
ALTEX; 2013; 30(1):1. PubMed ID: 23451363
[No Abstract] [Full Text] [Related]
13. The proportions of mutagens among chemicals in commerce.
Zeiger E; Margolin BH
Regul Toxicol Pharmacol; 2000 Oct; 32(2):219-25. PubMed ID: 11067778
[TBL] [Abstract][Full Text] [Related]
14. Introduction to the EU REACH legislation.
Grindon C; Combes R
Altern Lab Anim; 2008 Oct; 36 Suppl 1():1-6. PubMed ID: 19025328
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional cell cultures in toxicology.
Pampaloni F; Stelzer E
Biotechnol Genet Eng Rev; 2010; 26():117-38. PubMed ID: 21415878
[TBL] [Abstract][Full Text] [Related]
16. Mutagenicity test schemes and guidelines: U.S. EPA Office of Pollution Prevention and Toxics and Office of Pesticide Programs.
Auletta AE; Dearfield KL; Cimino MC
Environ Mol Mutagen; 1993; 21(1):38-45; discussion 46-57. PubMed ID: 8419153
[TBL] [Abstract][Full Text] [Related]
17. A critical appraisal of the process of regulatory implementation of novel in vivo and in vitro methods for chemical hazard and risk assessment.
Piersma AH; Ezendam J; Luijten M; Muller JJ; Rorije E; van der Ven LT; van Benthem J
Crit Rev Toxicol; 2014 Nov; 44(10):876-94. PubMed ID: 25058877
[TBL] [Abstract][Full Text] [Related]
18. REACH testing requirements must not be driven by reproductive toxicity testing.
Spielmann H; Vogel R
Altern Lab Anim; 2006 Aug; 34(4):365-6. PubMed ID: 16945004
[No Abstract] [Full Text] [Related]
19. A replacement-first approach to toxicity testing is necessary to successfully reauthorize TSCA.
Locke PA; Myers DB
ALTEX; 2011; 28(4):266-72. PubMed ID: 22130480
[TBL] [Abstract][Full Text] [Related]
20. Integrated testing strategy (ITS) for bioaccumulation assessment under REACH.
Lombardo A; Roncaglioni A; Benfentati E; Nendza M; Segner H; Fernández A; Kühne R; Franco A; Pauné E; Schüürmann G
Environ Int; 2014 Aug; 69():40-50. PubMed ID: 24806447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
